Gilead Sciences »

Merus N V shares owned by Gilead Sciences

Quarter-by-quarter ownership of Merus N V (MRUS) shares owned by Gilead Sciences from 13F filings

Historical chart of Gilead Sciences investment in Merus N V

23:59:59.999Dec 30, 202423:59:59.999500:00:00Dec 31, 202400:00:00.000500:00:00.00119.028759M19.0287595M19.02876M19.0287605M19.028761M452.526k452.5265k452.527k452.5275k452.528k
Value ($)Share countHistorical MRUS position of Gilead Sciences Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Merus N V held by Gilead Sciences consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merus N V by Gilead Sciences

Quarter filed Position value Share count Share price at filing
2024-12-31 $19M 453k 42.05

More positions owned by Gilead Sciences

Arcellx Common Stock (ACLX)
Galapagos Nv Spon Adr (GLPG)
Arcus Biosciences Incorporated (RCUS)
Assembly Biosciences Com New (ASMB)
Merus N V (MRUS)
Kyverna Therapeutics (KYTX)
Leap Therapeutics Com New (LPTX)
Tango Therapeutics (TNGX)
Xilio Therapeutics (XLO)
Allovir (ALVR)
Hookipa Pharma Com New (HOOK)
Ikena Oncology (IKNA)
Allogene Therapeutics (ALLO)
Barinthus Biotherapeutics Pl Ads (BRNS)
Agenus Com New (AGEN)

View all positions for Gilead Sciences

Top funds holding Merus N V

FMR
Rtw Investments
Commodore Capital
Wellington Management Company
Deerfield Management Company
Samlyn Capital
venBio Select Advisor
Franklin Resources
Boxer Capital Management
Holocene Advisors
Polar Capital Holdings
Paradigm Biocapital Advisors
Federated Investors
BlackRock
Lynx1 Capital Management

View all funds holding Merus N V